MNKD FY 2020 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$65M+3.3% YoY

Gross Profit

$41M62.2% margin

Operating Income

-$48M-73.5% margin

Net Income

-$57M-87.9% margin

EPS (Diluted)

$-0.26

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$33M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$109M

Total Liabilities

$289M

Stockholders' Equity

-$180M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$63M	+3.3%
Gross Profit	$41M	$35M	+15.5%
Operating Income	-$48M	-$45M	-7.4%
Net Income	-$57M	-$52M	-10.3%